Results for tag: "Cluster Headache Syndrome Drug"

Cluster Headache Syndrome (CHS) is a rare neurological disorder characterized by severe, debilitating headaches. It is estimated to affect approximately 0.1% of the population. Treatment for CHS is typically divided into two categories: acute and preventive. Acute treatments are used to provide immediate relief from the pain of a cluster headache attack, while preventive treatments are used to reduce the frequency and severity of attacks. The Cluster Headache Syndrome Drug market is a subset of the Central Nervous System Drugs market. It is composed of pharmaceuticals used to treat CHS, including triptans, ergot alkaloids, and corticosteroids. These drugs are typically administered orally, intranasally, or subcutaneously. The Cluster Headache Syndrome Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more